Stryker Corporation

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 16:00:02 2024-07-05 EDT			5-day change	1st Jan Change
337.2 ^USD	+1.58%		-0.88%	+12.62%

07-02	Evercore ISI Adjusts Price Target on Stryker to $365 From $370, Maintains Outperform Rating	MT
07-01	Stryker Corporation(NYSE:SYK) dropped from Russell 1000 Dynamic Index	CI

Stryker Corporation Announces Not to Provide Quarterly Guidance

January 27, 2021 at 04:08 pm

Stryker Corporation announced that it will continue to monitor and evaluate the impact the global response to the COVID-19 pandemic has had and will not be providing quarterly guidance.

Latest news about Stryker Corporation

Evercore ISI Adjusts Price Target on Stryker to $365 From $370, Maintains Outperform Rating	07-02	MT
Stryker Corporation(NYSE:SYK) dropped from Russell 1000 Dynamic Index	06-30	CI
Stryker Joins Atrium Health Affiliate IRCAD North America to Advance Surgical Training and Education	06-18	CI
Stryker Releases Lifepak 35 Monitor/Defibrillator	06-04	CI
Stryker to Acquire Artelon	06-03	MT
Stryker Corporation agreed to acquire Artelon, Inc.	06-02	CI
First European Announces That Surgeries Completed Using Stryker?s Gamma4 Hip Fracture Nailing System	05-29	CI
Stryker Insider Sold Shares Worth $668,308, According to a Recent SEC Filing	05-23	MT
Needham Upgrades Stryker to Buy From Hold, Notes Potential for Double-Digit Organic Revenue Growth; PT is $392	05-22	MT
Stryker Insider Sold Shares Worth $3,276,516, According to a Recent SEC Filing	05-16	MT
Everlasting momentum	05-16
ANALYST RECOMMENDATIONS : Ecolab, Texas Instruments, Cisco, Britvic, Shopify...	05-16
Stryker Keeps Quarterly Dividend at $0.80 a Share, Payable July 31 to Shareholders of Record on June 28	05-09	MT
Stryker Corporation Declares Quarterly Dividend, Payable on July 31, 2024	05-09	CI
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices	05-02	RE
UBS Adjusts Stryker Price Target to $351 From $339, Maintains Neutral Rating	05-01	MT
BTIG Adjusts Price Target on Stryker to $369 From $366	05-01	MT
Piper Sandler Adjusts Price Target on Stryker to $380 From $375	05-01	MT
Baird Adjusts Price Target on Stryker to $378 From $367	05-01	MT
Stifel Adjusts Price Target on Stryker to $375 From $350	05-01	MT
Oppenheimer Adjusts Price Target on Stryker to $360 From $350	05-01	MT
Roth MKM Adjusts Price Target on Stryker to $405 From $348	05-01	MT
Jefferies Adjusts Price Target on Stryker to $400 From $390, Keeps Buy Rating	05-01	MT
Bernstein Adjusts Price Target on Stryker to $393 From $385, Keeps Outperform Rating	05-01	MT
Nephron Research Raises Stryker's Price Target to $400 From $385	05-01	MT

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-30 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Stryker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

337.2 USD

Average target price

372.7 USD

Spread / Average Target

+10.52%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+12.62%	128B
SMITH & NEPHEW PLC	-1.99%	11.8B
GLAUKOS CORPORATION	+53.19%	6.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-23.60%	6.65B
INSPIRE MEDICAL SYSTEMS, INC.	-30.75%	4.19B
ENOVIS CORPORATION	-19.96%	2.46B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-17.14%	1.94B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-21.05%	1.75B
DOUBLE MEDICAL TECHNOLOGY INC.	-37.13%	1.45B
MEDARTIS HOLDING AG	-16.31%	1.06B

Medical Devices & Implants